Single Convention

FDA called for de-scheduling of CBD: report

Posted on October 3rd, 2018 by Global Ganja Report and tagged , , , , , , , .

cannabisLast month, the DEA enthused the pharmaceutical industry but disappointed cannabis advocates by re-scheduling the drug Epidiolex—but not CBD, the cannabinoid that makes it work. Now word emerges of a letter to the DEA by the Food & Drug Administration essentially calling for the descheduling of CBD altogether.

DEA reschedules Epidiolex —but not CBD

Posted on September 27th, 2018 by Global Ganja Report and tagged , , , , , , , , .

EpidiolexWith the DEA's rescheduling of Epidiolex, shares in the British manufacturer of the drug are soaring. But CBD—the actual cannabinoid that the product is based on—is to remain in the restrictive Scheudle 1.

Activists bash Trump's 'Global Call' to renew drug war at UN

earthAs the UN General Assembly met in New York, President Trump issued a "Global Call" to renew the war on drugs—to the dismay of activists and dissenting nations. But the UN itself has a contradictory cannabis policy—with some agencies recognizing its efficacy as medicine and others backing the prohibitionist doctrine of the Single Convention treaty.

Tax relief for 'compassionate care' pending in Sacramento

Posted on September 12th, 2018 by Global Ganja Report and tagged , , , , , , , .

CaliforniaAmong several cannabis-related bills that cleared California's state house before the last legislative session came to close is one that would lift the tax burden on medical marijuana providers. The bill is intended to again open space for "compassionate care," which was ironically squeezed out under California's adult-use regulation regime. 

Health benefits of THC overlooked in CBD-mania?

Posted on August 22nd, 2018 by Bill Weinberg and tagged , , , , , , , , .

THCHaving just undertaken a "critical study" of CBD, the non-psychoactive cannabinoid held to have multifarious medicinal applications, the World Health Organization is now opening such a study on THC. Stigmatized due to its psychoactive properties and currently in the shadow of the suddenly sexy CBD, tetrahydrocannabinol shows its own potential for application by the medical industry.

Medical cannabis products to finally be legal in United Kingdom —but which ones?

Posted on July 27th, 2018 by Global Ganja Report and tagged , , , , , , .

extractThe British government has finally capitulated to pressure from patients, activists and even regional authorities, and officially pledged to make medical cannabis products available on prescription this year. But it remains to be seen which products will win approval—and actual herbaceous cannabis is unlikely to make the cut.

California bans hemp-derived CBD oil

Posted on July 16th, 2018 by Global Ganja Report and tagged , , , , , , , , , , , , , .

extractCalifornia health authorities dealt a blow to the burgeoning CBD business by banning preparations of the cannabinoid derived from industrial hemp rather than psychoactive cannabis. The diktat adds to the legal confusion around CBD, and highlights the need for greater clarity from the competent authorities at both the state and federal level.

Appeals court upholds CBD's status as controlled substance

Posted on May 7th, 2018 by Global Ganja Report and tagged , , , , , , , , , , , .

cannabisA federal appeals court has turned down a challenge by the cannabis industry to the DEA's official finding that CBD is a controlled substance. But questions about whether CBD should be treated as a controlled substance remain pending at the state level.

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman